Cohort (n=473,483)
Yes
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sutapat Thiprungsri (2012) conducted a cohort in Type 2 diabetes mellitus (n=473,483). Rosiglitazone monotherapy vs. Metformin monotherapy was evaluated on Any cardiovascular event (including myocardial infarction, congestive heart failure, angina pectoris, stroke, and transient ischaemic attack) (HR 1.89, 95% CI 1.57-2.28).